Organizations are increasingly evaluating their potential to reshore their life sciences manufacturing, particularly to U.S. territories such as Puerto Rico. This trend is being fueled by mounting global instability, policy pressure, and supply chain disruption and uncertainty, presenting a compelling strategic opportunity for organizations. Today’s forward-thinking firms are reexamining their global trade strategy through the lens of both resilience and value creation, with relocation as one way to achieve improved stability.  

For organizations, relocation is a strategic repositioning aimed at mitigating risk, strengthening market access, and driving sustainable growth. Below, we explore how deliberate what-if analysis and scenario planning, local investment, and technology enablement can maximize the benefits of relocation, offering organizations improved cost predictability, supply chain resilience, and closer alignment with U.S. regulations.  

Reassessing Global Value Chains in a Volatile World 

Research has shown that pharmaceutical and biotech companies who have supply chains that can respond nimbly to global shocks are better positioned to sustain a competitive advantage. Given today’s trade volatility, the imperative to localize production and reduce reliance on distant hubs has never been stronger. 

U.S. territories offer a unique nexus of benefits:  regulatory familiarity, tax incentives, and access to skilled labor, for example. Proximity to major U.S. and Latin American markets also enables faster delivery timelines, better service levels, and enhanced customer trust. When it comes to supply chain resilience, reconfiguring your global networks is no longer an option; rather, it’s a strategic imperative for organizations wanting to compete and succeed in today’s volatile marketplace. 

Key Drivers: Cost Optimization, Tariff Mitigation, and Local Enablement 

For companies serving U.S. markets, relocation manufacturing operations to U.S. territories can help meaningfully reduce their tariff exposure and leverage available tax advantages, free trade zones, and duty deferrals. These strategies support more predictable margins and cost structures. However, the opportunity extends far beyond financial engineering. 

Long-term success hinges on deeper engagement with local ecosystems. By partnering with regional governments and educational institutions, firms can build robust talent pipelines that not only support operations but also create shared economic value.  

We also recommend companies utilize supply chain diagnostic tools, or industry-specific accelerator methods, to uncover potential risks and optimization opportunities early in the what-if scenario planning cycle for relocation. 

Policy Volatility and Risk Mitigation: Hedging Your Global Trade Strategy for the See-Saw Effect 

Relocation strategies must account for more than challenges of the moment, such as shortages of critical sterile inputs (e.g., sterile injectables and single-use bioprocessing materials), increased scrutiny of foreign API sourcing, and tightening global regulatory expectations.  

Organizations must also anticipate future shifts driven by evolving U.S. trade, tax, and regulatory policies. The “see-saw” effect of administration changes can dramatically impact tariffs, incentives, and regulatory enforcement over a 4- to 8-year cycle, creating significant uncertainty for long-term investments. To mitigate relocation risks and build resilience, life sciences organizations should: 

• Design Modular Supply Networks: Structure operations with flexible, multi-site capabilities that allow production and distribution to be rebalanced as policies evolve. 
• Secure Strategic Trade Classifications: Carefully review and optimize product classifications under HTS codes to reduce exposure to abrupt tariff changes. 
• Utilize Trade and Tariff Acceleration Tools: Leveraging accelerator tools and global trade readiness diagnostics to reveal hidden risks and optimize compliance strategies early in the transition process. 
• Maintain Active Policy Monitoring: Establish a monitoring function, either internal or through trusted advisory partners, to track regulatory and trade developments and proactively adjust operational plans. 
• Diversify Talent and Supplier Ecosystems: Build partnerships across multiple U.S. territories and nearby international markets to avoid over-dependence on a single location. 

The process to move or relocate a life sciences manufacturing facility is no simple task, and choosing the right relocation site is just the start. Relocating a life sciences manufacturing operation across borders is a high-stakes, multi-year transformation.   

From tech transfer and regulatory approvals to workforce ramp-up and equipment qualification, the process can take anywhere from 18 to 36 months as the complexity spans operational, financial, and compliance functions. However, evaluating the long-term global landscape, and making prudent adjustments based on the current certainties, can provide a real strategic advantage for companies as they look to navigate tariff risk through an integrated, forward-looking global trade strategy. 

Call to Action: Embracing Flexibility and Adaptability   

For today’s life sciences companies, the decision is no longer whether to localize manufacturing, but how to do so strategically and sustainably. Instead, maintaining and adjusting your global trade strategy is essential to ensure resilience and compliance. By approaching relocation as a transformation initiative rather than a logistical exercise, companies can future-proof operations, strengthen competitive advantage, and realize new value across their supply chains. 

It’s important, though, to remember that changes in global trade factors, such as tariffs, impact more than just the supply chain. In fact, every function across your organization can be impacted by uncertainty in international trade relations. The key to navigating this uncertainty is by taking a flexible, adaptable approach, recognizing that there isn’t a one-size-fits-all solution.  

Click here to learn more about our global trade strategy consulting services.